體外受精顯微鏡市場 - 按產品類型（胚胎、立體、直立、倒置）、最終用途（臨床、學術研究） - 全球預測 2024 年 - 2032 年

In-vitro Fertilization Microscope Market - By Product Type (Embryo, Stereo, Upright, Inverted), End-use (Clinical, Academic Research) - Global Forecast 2024 - 2032

出版日期: 2024年03月13日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在輔助生殖技術 (ART) 進步的推動下，體外受精顯微鏡市場預計 2024 年至 2032 年複合年成長率將達到 8.5%。隨著越來越多的夫婦面臨不孕問題並尋求醫療干預來懷孕，對體外受精 (IVF) 顯微鏡等專業設備的需求正在激增。根據世界衛生組織的數據，全球成年人口中約有 17.5%（即約六分之一的人）面臨不孕問題。此外，已開發國家和發展中經濟體對生育治療的認知不斷提高，加上可支配收入不斷增加，刺激了體外受精程序的採用。

高解析度成像系統的發展以及延時成像和自動胚胎評估等功能提高了 IVF 程序的準確性和效率。這些進步不僅提高了生育治療的成功率，還簡化了 IVF 實驗室的工作流程，吸引醫療保健提供者投資最先進的顯微鏡解決方案。

體外受精顯微鏡產業根據產品類型、最終用途和地區進行分類。

根據產品，體視顯微鏡領域的市場價值將在2024 年至2032 年間呈現8.6% 的成長率。精緻的標本過程。此外，這些顯微鏡的人體工學設計和使用者友善的介面有助於提高 IVF 實驗室的工作流程效率。

在創新和對生殖生物學更廣泛理解的支持下，學術研究最終用途領域的體外受精顯微鏡市場預計到 2032 年複合年成長率將達到 8.9%。學術機構協助進行突破性研究，以改善生育治療和推進輔助生殖技術。隨著研究人員探索新的方法和技術來提高胚胎髮育和植入成功率，針對 IVF 研究特定需求客製化的高品質顯微鏡設備的需求不斷成長。

由於不孕問題日益普遍，到 2032 年，亞太地區體外受精顯微鏡產業將實現 9.1% 的成長率。在醫療保健基礎設施方面已經有了重大舉措和投資，特別是在中國、印度和日本等國家。此外，龐大的人口基數和不斷提高的醫療保健標準將有助於該地區對體外受精顯微鏡的需求不斷成長。

產業生態系統分析
產業影響力
- 成長動力
  - 由於成功率提高，採用率提高
  - 不斷進步的技術進步
  - 政府政策不斷升級
- 產業陷阱與挑戰
  - 限制 IVF 指南
  - 商品化和工業化
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年

主要趨勢
胚胎顯微鏡
體視顯微鏡
正置顯微鏡
倒置顯微鏡

第 6 章：市場估計與預測：依最終用途，2018 - 2032 年

主要趨勢
診所
學術研究
其他最終用戶

第 7 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Eppendorf AG
Euromex Microscopen BV
Hamilton Thorne Ltd.
Labomed, Inc.
Leica Microsystems A/S (Danaher Corporation)
Linkam Scientific Instruments Limited
Meiji Techno
NARISHIGE Group
Nikon Corporation
Olympus Corporation
Sutter Instrument Company

簡介目錄

Product Code: 8485

In-vitro fertilization microscope market is estimated to record 8.5% CAGR from 2024 to 2032, driven by advancements in assisted reproductive technologies (ART). As more number of couples face infertility issues and seek medical interventions to conceive, the demand for specialized equipment like In-vitro fertilization (IVF) microscopes is surging. As per WHO, approximately 17.5% of the global adult population, roughly 1 in 6 individuals face infertility issues. Additionally, increasing awareness about fertility treatments coupled with rising disposable incomes in both developed and developing economies has spurred the adoption of IVF procedures.

The development of high-resolution imaging systems, along with features like time-lapse imaging and automated embryo assessment, has enhanced the accuracy and efficiency of IVF procedures. These advancements not only improve the success rates of fertility treatments but also streamline the workflow in IVF laboratories, attracting healthcare providers to invest in state-of-the-art microscopy solutions.

The in-vitro fertilization microscope industry is classified based on product type, end-use and region.

Based on product, the market value from the stereo microscopes segment will exhibit 8.6% growth rate between 2024 and 2032. Stereo microscopes offer enhanced depth perception and three-dimensional visualization capabilities, allowing embryologists to manipulate delicate specimens with precision during various stages of the IVF process. Additionally, the ergonomic design and user-friendly interface of these microscopes is contributing to improved workflow efficiency in IVF laboratories.

In- vitro fertilization microscope market from the academic research end-use segment is expected to witness 8.9% CAGR through 2032, backed by innovations and wider understanding of reproductive biology. Academic institutions help in conducting groundbreaking research for improving fertility treatments and advancing assisted reproductive technologies. As researchers explore new methodologies and techniques to enhance embryo development and implantation success rates, there is a growing demand for high-quality microscopy equipment tailored to the specific needs of IVF research.

Asia Pacific in-vitro fertilization microscope industry will record a 9.1% growth rate through 2032, attributed to the increasing prevalence of infertility issues. There have been significant initiatives and investments in healthcare infrastructure, particularly in countries, such as China, India, and Japan. Furthermore, the presence of a large population base and improving healthcare standards will contribute to the burgeoning demand for IVF microscopy in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increased adoption due to improving success rate
  - 3.2.1.2 Rising technological advancements
  - 3.2.1.3 Rising government policies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Restraining IVF guidelines
  - 3.2.2.2 Commoditization and industrialization
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Embryo microscopes
5.3 Stereo microscopes
5.4 Upright microscopes
5.5 Inverted microscopes

Chapter 6 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Clinics
6.3 Academic research
6.4 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa